AB0230 Polymorphism of Cytotoxic T-Lymphocyte 4 +49a/G Is Associated With Early Prescribing the Biological Therapy in Active Early Rheumatoid Arthritis Patients (ERA PTS) Refractory to the Previous Subcutaneous Methotrexate (SC MTX) Monotherapy
doi 10.1136/annrheumdis-2017-eular.3023
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2017
Authors
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism